By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Complete Genomics, reporting for the first time as a public company, said Friday after the close of the market that it generated revenues of $4.2 million for the third quarter compared to no revenues for Q3 2009.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.
In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.
At Nature, John Wilbanks and Eric Topol call for openness in health data.
Law.com predicts that genomic and genetic testing will become common in toxic tort cases.